Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”

Detalles Bibliográficos
Autores principales: Still, Daniel, Do, Kathy, Thompson, Paul, Brackins, Todd, McGrory, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Psychiatric Pharmacists 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337883/
https://www.ncbi.nlm.nih.gov/pubmed/37448830
http://dx.doi.org/10.9740/mhc.2023.06.165
_version_ 1785071511477944320
author Still, Daniel
Do, Kathy
Thompson, Paul
Brackins, Todd
McGrory, James
author_facet Still, Daniel
Do, Kathy
Thompson, Paul
Brackins, Todd
McGrory, James
author_sort Still, Daniel
collection PubMed
description
format Online
Article
Text
id pubmed-10337883
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association of Psychiatric Pharmacists
record_format MEDLINE/PubMed
spelling pubmed-103378832023-07-13 Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” Still, Daniel Do, Kathy Thompson, Paul Brackins, Todd McGrory, James Ment Health Clin Letter to the Editor American Association of Psychiatric Pharmacists 2023-06-28 /pmc/articles/PMC10337883/ /pubmed/37448830 http://dx.doi.org/10.9740/mhc.2023.06.165 Text en © 2023 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists. https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Still, Daniel
Do, Kathy
Thompson, Paul
Brackins, Todd
McGrory, James
Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
title Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
title_full Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
title_fullStr Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
title_full_unstemmed Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
title_short Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
title_sort comment on “an update on recently approved long-acting injectable second-generation antipsychotics: knowns and unknowns regarding their use”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337883/
https://www.ncbi.nlm.nih.gov/pubmed/37448830
http://dx.doi.org/10.9740/mhc.2023.06.165
work_keys_str_mv AT stilldaniel commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse
AT dokathy commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse
AT thompsonpaul commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse
AT brackinstodd commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse
AT mcgroryjames commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse

Ejemplares similares